Geron (GERN) Receivables (2015 - 2026)
Geron's (GERN) quarterly Receivables came in at $53.5 million in Q2 2026, up 35.92% year-over-year from $39.4 million in Q2 2025, and up 21.34% quarter-over-quarter from $44.1 million in Q1 2026.
Analysis
Geron (GERN) Receivables (2015 - 2026) Analysis & Trends
Geron has disclosed Receivables across 5 years of filings, most recently posting $53.5 million for Q2 2026.
- In Q2 2026, Receivables rose 35.92% year-over-year to $53.5 million; the TTM figure through Jun 2026 stood at $53.5 million (up 35.92% YoY), while the FY2025 annual figure was $39.2 million, up 1.1% from the prior year.
- Receivables came in at $53.5 million for Q2 2026 at Geron, up from $44.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $53.5 million in Q2 2026 to a low of $3.1 million in Q2 2024.
- Average Receivables over 3 years is $35.5 million, with a median of $38.8 million recorded in 2024.
- The largest YoY upside for Receivables was 1159.21% in 2025 against a maximum downside of 1.1% in 2025.
- Over 3 years, Receivables stood at $38.8 million in 2024, then increased by 1.1% to $39.2 million in 2025, then surged by 36.4% to $53.5 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $53.5 million in Q2 2026, $44.1 million in Q1 2026, and $39.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | 53.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.50 Mn |
| Mar 31, 2026 | 44.10 Mn |
| Dec 31, 2025 | 39.23 Mn |
| Sep 30, 2025 | 37.66 Mn |
| Jun 30, 2025 | 39.36 Mn |
| Mar 31, 2025 | 33.98 Mn |
| Dec 31, 2024 | 38.80 Mn |
| Sep 30, 2024 | 30.09 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Sep 30, 2016 | 5.40 Mn |
| Dec 31, 2015 | 2.41 Mn |